欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

秘鲁制药和医疗保健行业报告(2019-2020年)

Peru Pharma and Healthcare Sector Report 2019-2020

加工时间:2019-04-23 信息来源:EMIS 索取原文[73 页]
关键词:秘鲁制药;医疗保健行业;竞争程度;细分市场;竞争程度较低;经营五家制药链;健康保险;医疗保险;公共医疗保险计划(SIS);社会保障健康 保险计划(EsSalud)
摘 要:

The level of competition in Peru’s pharma and healthcare sector varies across segments. Pharmaceutical retail exhibits a low degree of competition, with one Peruvian company – InRetail Peru – operating five pharmaceutical chains (i.e. Inkafarma, Vanttive, BTL, FASA and MiFarma), which accounted for 58% of drug sales in value terms in 2017. Health insurance is largely controlled by the government, which runs both the public health insurance scheme (SIS) and the social security health insurance scheme (EsSalud). However, the still small private health insurance market has recently grown in size and number of players, registering a moderate degree of competition.


目 录:

01 EXECUTIVE SUMMARY 

02 SECTOR IN FOCUS 

03 COMPETITIVE LANDSCAPE 

04 COMPANIES IN FOCUS

05 REGULATORY ENVIRONMENT 

06 PHARMACEUTICALS 

07 HEALTHCARE 

08 RETAIL CHANNELS


© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服